Appropriate Strategy of Surgical Treatment in Ischemic Diabetic Foot
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04709887 |
|
Recruitment Status :
Recruiting
First Posted : January 14, 2021
Last Update Posted : January 19, 2021
|
Sponsor:
Peking University People's Hospital
Information provided by (Responsible Party):
Hailin Xu, Peking University People's Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Brief Summary:
This cohort study aims to evaluate the outcomes of appropriate surgical treatment strategies in diabetic foot ulcers with different rate of popliteal artery stenosis(<50% or ≥50%). In this study, patients with Texas university grade 2-4(stage C-D) ischemic diabetic foot ulcers will be included. Data of patients who underwent surgical treatment in the past will be retrospectively collected. The patients with follow-up time less than 12 months will continue to follow up. Also the postoperative patients will be prospectively collected. Effects of different surgical strategies, including wound healing therapy, interventional therapy and tibial transverse bone transport therapy will be measured by several indexes.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Diabetic Foot Ischemic Diabetic Foot Ulcer Popliteal Artery Stenosis | Procedure: Wound treatment Procedure: Vascular intervention surgery Procedure: Tibial transverse transport surgery | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 332 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Appropriate Strategy of Surgical Treatment in Ischemic Diabetic Foot |
| Actual Study Start Date : | January 1, 2017 |
| Estimated Primary Completion Date : | January 1, 2022 |
| Estimated Study Completion Date : | January 1, 2024 |
Resource links provided by the National Library of Medicine
| Arm | Intervention/treatment |
|---|---|
|
Rate of popliteal artery stenosis < 50%, W.
If the rate of popliteal artery stenosis of patients < 50%, the patients only receive the wound treatment.
|
Procedure: Wound treatment
According to the guidelines and recommendations of the International Diabetic Foot Working Group, ulcer surface debridement, negative pressure suction drainage, and routine dressing were performed until the wound healed or the end of the trial. |
|
Rate of popliteal artery stenosis < 50%, WT.
If the rate of popliteal artery stenosis of patients < 50%, the patients receive the wound treatment and tibial transverse transport surgery.
|
Procedure: Wound treatment
According to the guidelines and recommendations of the International Diabetic Foot Working Group, ulcer surface debridement, negative pressure suction drainage, and routine dressing were performed until the wound healed or the end of the trial. Procedure: Tibial transverse transport surgery In the anteromedial area of the proximal tibia of the affected limb, the external fixation frame was compared with the area along the midline of the medial longitudinal axis of the proximal tibia. Subsequently, two 3.0 Steinmann pins were inserted through the single layer of cortical bone. The skin was cut along the long axis with the 3.0 Steinmann pin as the centre, and the subcutaneous tissue was separate bluntly to expose the periosteum. The Steinmann pins were used as the centre point for the drilling on four sides with a 2.0 drill bit and use of a rapid osteotomy device; the length of each side was 2.5 cm. Subperiosteal osteotomy was performed with a 5-mm narrow bone knife at an angle of 15°-30° to the bone surface. The surgeons should pay attention to protect the blood supply of the periosteum during this procedure. The external fixators were fixed with 4.0 Steinmann pins at the distal and proximal ends. The subcutaneous tissue and skin were sutured. |
|
Rate of popliteal artery stenosis ≥ 50%, WV.
If the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and vascular intervention surgery.
|
Procedure: Wound treatment
According to the guidelines and recommendations of the International Diabetic Foot Working Group, ulcer surface debridement, negative pressure suction drainage, and routine dressing were performed until the wound healed or the end of the trial. Procedure: Vascular intervention surgery Segmented distal angiography under the guidance of digital subtraction angiography (DSA) were perform after local anesthesia. The superficial artery is expanded by a 3-4 mm balloon. |
|
Rate of popliteal artery stenosis ≥ 50%, WT.
If the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment and tibial transverse transport surgery.
|
Procedure: Wound treatment
According to the guidelines and recommendations of the International Diabetic Foot Working Group, ulcer surface debridement, negative pressure suction drainage, and routine dressing were performed until the wound healed or the end of the trial. Procedure: Tibial transverse transport surgery In the anteromedial area of the proximal tibia of the affected limb, the external fixation frame was compared with the area along the midline of the medial longitudinal axis of the proximal tibia. Subsequently, two 3.0 Steinmann pins were inserted through the single layer of cortical bone. The skin was cut along the long axis with the 3.0 Steinmann pin as the centre, and the subcutaneous tissue was separate bluntly to expose the periosteum. The Steinmann pins were used as the centre point for the drilling on four sides with a 2.0 drill bit and use of a rapid osteotomy device; the length of each side was 2.5 cm. Subperiosteal osteotomy was performed with a 5-mm narrow bone knife at an angle of 15°-30° to the bone surface. The surgeons should pay attention to protect the blood supply of the periosteum during this procedure. The external fixators were fixed with 4.0 Steinmann pins at the distal and proximal ends. The subcutaneous tissue and skin were sutured. |
|
Rate of popliteal artery stenosis ≥ 50%, WVT.
If the rate of popliteal artery stenosis of patients ≥ 50%, the patients receive the wound treatment, vascular intervention and tibial transverse transport surgery.
|
Procedure: Wound treatment
According to the guidelines and recommendations of the International Diabetic Foot Working Group, ulcer surface debridement, negative pressure suction drainage, and routine dressing were performed until the wound healed or the end of the trial. Procedure: Vascular intervention surgery Segmented distal angiography under the guidance of digital subtraction angiography (DSA) were perform after local anesthesia. The superficial artery is expanded by a 3-4 mm balloon. Procedure: Tibial transverse transport surgery In the anteromedial area of the proximal tibia of the affected limb, the external fixation frame was compared with the area along the midline of the medial longitudinal axis of the proximal tibia. Subsequently, two 3.0 Steinmann pins were inserted through the single layer of cortical bone. The skin was cut along the long axis with the 3.0 Steinmann pin as the centre, and the subcutaneous tissue was separate bluntly to expose the periosteum. The Steinmann pins were used as the centre point for the drilling on four sides with a 2.0 drill bit and use of a rapid osteotomy device; the length of each side was 2.5 cm. Subperiosteal osteotomy was performed with a 5-mm narrow bone knife at an angle of 15°-30° to the bone surface. The surgeons should pay attention to protect the blood supply of the periosteum during this procedure. The external fixators were fixed with 4.0 Steinmann pins at the distal and proximal ends. The subcutaneous tissue and skin were sutured. |
Primary Outcome Measures :
- Healing rate of wound surface [ Time Frame: 12 months after surgical operation ]
Secondary Outcome Measures :
- Ankle-brachial index [ Time Frame: 3 months after surgical operation ]
- Ankle-brachial index [ Time Frame: 12 months after surgical operation ]
- Recurrence rate of foot ulcer [ Time Frame: 12 months after surgical operation ]
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patients with diabetic foot, according to "Chinese Guidelines for Diagnosis and Treatment of Diabetic Foot (2017)".
- Texas university grade 2-4(stage C-D) ischemic diabetic foot ulcers.
- Have clear consciousness, not suffer from mental illness, can cooperate in research and treatment.
- Patients who are informed, participate in the research voluntarily, and have signed the informed consent.
- Have complete clinical data.
Exclusion Criteria:
- Patients with severe systemic infection, who need to be amputated immediately to save lives.
- Patients with mental illness, who cannot cooperate to complete the adjustment and nursing of the external fixator.
- Patients with severe cardiovascular and cerebrovascular diseases (such as severe cardiac insufficiency, severe sequelae of cerebrovascular disease), or with acute infectious diseases.
- Have used or using glucocorticoids systemically within 3 months before admission.
- Have participated in other medical clinical trials within 3 months before admission.
- Patients with severe liver or kidney function abnormalities
- Pregnant or lactating women.
- Patients who lost follow-up.
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04709887
Contacts
| Contact: Yusong Yuan, Master | +86 18801229862 | xiaxi@pku.edu.cn |
Locations
| China | |
| Peking University People's Hospital | Recruiting |
| Beijing, China | |
| Contact: Hailin Xu, MD | |
Sponsors and Collaborators
Peking University People's Hospital
Investigators
| Study Director: | Hailin Xu, MD | Peking University People's Hospital |
| Responsible Party: | Hailin Xu, Associate Professor, Peking University People's Hospital |
| ClinicalTrials.gov Identifier: | NCT04709887 |
| Other Study ID Numbers: |
mTTTDFU01 |
| First Posted: | January 14, 2021 Key Record Dates |
| Last Update Posted: | January 19, 2021 |
| Last Verified: | January 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
Keywords provided by Hailin Xu, Peking University People's Hospital:
|
Ischemic Diabetic Foot Ulcer Surgical Strategy Cohort study |
Additional relevant MeSH terms:
|
Diabetic Foot Foot Ulcer Ischemia Pathologic Processes Diabetic Angiopathies Vascular Diseases Cardiovascular Diseases Leg Ulcer |
Skin Ulcer Skin Diseases Diabetes Complications Diabetes Mellitus Endocrine System Diseases Diabetic Neuropathies Foot Diseases |